santa cruz biotechnology, inc.

| |
|
| | Posttranslational Modification Reagents
- α-Hydroxyfarnesyl-phosphonic acid
α-Hydroxyfarnesylphosphonic acid potently inhibits farnesyltransferase in isolated enzyme assays and in whole cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200852 | 140633-12-1 | C15H27O4P | 1 mg |
- Chaetomellic acid A
This is a potent inhibitor of farnesyltransferase in isolated enzyme assays (IC50=55nM) but it is inactive in whole cells. Inhibition of farnesyltransferase is selective over geranylgeranyltransferase I and II (IC50=92µM and 34µM respectively).| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221420 | 148796-51-4 | C19H32O4 ·2Na | 5 mg/25 mg |
- Farnesyl Thiosalicylic Acid
A farnesylcysteine mimic, blocks anchorage of Ras proteins to the membrane and to protein escorts. Decreases cellular Ras levels. Inhibits PPMTase methylation of Ras.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205322 | 162520-00-5 | C22H30O2S | 1 mg/5 mg |
- Farnesylpyrophosphate
Farnesylpyrophosphate is an isoprenoid farnesyl-donor which is utilized by farnesyltransferase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200847 | 13058-04-3 | C15H25O7P2 ·3NH4 | 200 µg/5 mg |
- FPT Inhibitor I
A highly selective and potent inhibitor of farnesyltransferase. Exhibits inhibition of GGTase I and II at much higher concentrations.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221625 | n.n. | C19H29NO6P•3Na | 1 mg |
- FPT Inhibitor II
A cell permeable potent and selective inhibitor of farnesyltransferase. Is resistant to cleavage by phosphorylation. And inhibits Ras farnesylation in whole cells. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221626 | n.n. | C17H34NNa2O6P | 1 mg |
- FPT Inhibitor III
A cell-permeable prodrug ester form of farnesyltransferase (FTase) inhibitor II. Preventing Ras-mediated transformation by inhibiting Ras processing in cells. Also inhibits C15 and C20 protein prenylation in NIH-3T3 cells. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221627 | n.n. | C23H39NO7P•Na | 1 mg |
- FTase Inhibitor I
A potent, cell-permeable, selective, peptidomimetic inhibitor of FTase. It is ~37-fold more active against FTase than against geranylgeranyltransferase. Is also very resistant to proteolysis. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221632 | 149759-96-6 | C22H38N4O3S2 | 1 mg |
- FTase Inhibitor II
A potent FTase inhibitor. Prevents the farnesylation of Ras, which then results in its inability to associate with other cell signaling components in the cell.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221633 | n.n. | C15H21N3O4S2 | 1 mg |
- FTI-2148
An imidazolo-containing peptidomimetic that preferentially inhibits protein farnesyltransferase activity compared to protein geranylgeranyltransferase-I. Has been shown to disrupt Ras farnesylation in H-Ras-transformed NIH3T3 cells and prevent the growth of T. brucei rhodesiense and T. brucei brucei.
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221634 | n.n. | C24H28N4O3S ·2CF3CO2H | 500 µg |
- FTI-2628
A cell-permeable benzyl ester prodrug form of FTI-2148 that preferentially inhibits protein farnesyltransferase activity over protein geranylgeranyltransferase-I. Displays anti-malarial properties. Also suppresses parasitemia in P. berghei-infected mice by 46.1% with no apparent toxicity. Potently disrupts Ras farnesylation in H-Ras-transformed NIH 3T3 cells and inhibits the growth of P. falciparum in red blood cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221635 | n.n. | C31H34N4O3S | 500 µg |
- FTI-276
A highly potent and selective CAAX peptidomimetic of the carboxyl terminal of Ras proteins that inhibits FTase in vitro. Inhibits GGTase I at a much higher concentration. Has been shown to selectively block the growth of a human lung carcinoma expressing oncogenic K-Ras in nude mice. Also inhibits oncogenic signaling and tumor growth of NIH 3T3 cells transformed with the Ras oncogene at 20 µM. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221636 | n.n. | C21H27N3O3S2 | 250 µg |
- FTI-276 trifluoroacetate salt
A highly potent RasCAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling. This compound inhibits farnesyltransferase (Ftase) in vitro with an IC50 of 500 pM. Used as an anti-cancer agent. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-215057 | 170006-72-1 (non-salt) | C23H28F3N3O5S2 | 1 mg/5 mg |
- FTI-277 trifluoroacetate salt
Inhibitor of farnesyltransferase (Ftase). Highly potent (pM/nM) Ras CAAX peptidomimetic which antagonizes both H and K-Ras oncogenic signaling.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-215058 | 170006-73-2 (free base) | C22H29N3O3S2 ·xC2HF3O2 | 1 mg/5 mg |
- Geranylgeranylpyrophosphate triammonium salt
Geranylgeranylpyrophosphate is a geranylgeranyl-donor molecule which is utilized by geranylgeranyltransferase for isoprenylation of target proteins.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200849 | 6699-20-3 (non-salt) | C20H36O7P2•3NH3 | 200 µg |
- GGTI-2133
A cell-permeable non-thiol peptidomimetic that acts as a potent and selective inhibitor of GGTase I with a 140-fold selectivity relative to FTase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221668 | n.n. | C27H28N4O3 | 250 µg |
- GGTI-2147
A cell-permeable non-thiol peptidomimetic that acts as a strong and selective inhibitor of GGTase I. Blocks the geranyl-geranylation of Rap1A with an IC50 value that is over 60-fold lower than that required to disrupt the farnesylation of H-Ras. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221669 | n.n. | C28H30N4O3 | 250 g |
- GGTI-286
A potent, cell-permeable, and selective inhibitor of GGTase I. This methyl ester derivative of GGTI-287 is about 25-fold more potent than FTI-277 in inhibiting the processing of the geranylgeranylated protein Rap1A. GGTI-286 has also been shown to have a significant antiproliferative effect in human malignant glioma cells. It also selectively antagonizes oncogenic K-Ras4B.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221670 | 171744-11-9 | C23H31N3O3S | 250 µg |
- GGTI-287
A highly potent and selective peptidomimetic inhibitor of GGTase I than FTase in vitro.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221671 | n.n. | C22H29N3O3S | 250 µg |
- GGTI-297
A potent, cell-permeable, and selective peptidomimetic inhibitor of GGTase I compared to FTase | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221672 | n.n. | C26H31N3O3S | 250 µg/1 mg |
- L-744,832 Dihydrochloride
Ras farnesyltransferase inhibitor. Induces tumor regression in transgenic mice with multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis1. Induces p21 expression and arrests cells at G12. Causes enhanced mitotic sensitivity to taxol3.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221800 | 1177806-11-9 (free acid) | C26H45N3O6S2•2HCl | 5 mg/25 mg |
- Manumycin A
An antibiotic generated by Streptomyces parvulus that acts as a selective and vigorous inhibitor of Ras farnesyltransferase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200857 | 52665-74-4 | C31H38N2O7 | 1 mg |
- N-Acetyl-S-farnesyl-L-cysteine (AFC)
AFC specifically inhibits the S-farnesylcysteine methyl transferase in cell free extracts and in whole cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200839 | 135304-07-3 | C20H33NO3S | 5 mg/25 mg |
- N-Acetyl-S-geranyl-L-cysteine (AGC)
AGC is a close structural analog of AFC and AGGC but is biologically inactive. It may be used as a negative control for either AFC1 or AGGC2.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-221983 | n.n. | C15H25NO3S | 5 mg/25 mg |
- N-Acetyl-S-geranylgeranyl-L-cysteine (AGGC)
Shown to inhibit Ras carboxyl methylation which causes a decrease in cell proliferation. Also noted to be a competitive inhibitor for prenylcysteine methyl transferase. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200843 | 139332-94-8 | C25H41NO3S | 5 mg/25 mg |
- Perillic Acid
Shown to elicit cytotoxicity, induce cell cycle arrest, and apoptosis via an increase in expression of p21, Bax, and caspase-3 in cells. Also has been reported to be a major metabolite of d-limonene.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-200841 | 23635-14-5 | C10H14O2 | 100 mg/500 mg |
- 2-PCPA (hydrochloride)
Histones contain unstructured N-terminal residues that are the site of numerous post-translational modifications, involving acetylation, ubiquitination, methylation, and sumoylation to produce a specific gene regulatory outcome. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-220762 | n.n. | C9H12ClN | 10 mg/5 mg |
- S-Farnesyl-L-cysteine Methyl Ester
Stimulates the multidrug resistance transporter ATPase activity (4-5-fold at 10-20 µM) and competes for drug binding.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-222275 | n.n. | C19H33NO2S | 5 mg/25 mg |
|